TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
CGEM

Cullinan Oncology LLC

Healthcare · Biotechnology

15.20$ +1.9% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Cullinan Oncology LLC (CGEM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 364 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGEM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
495 484 449 681 653 622 580 520 484 448 403 364
477 480 446 678 592 415 318 276 342 387 361 342
65 98 74 115 102 83 77 73 103 88 75 79
466 467 433 662 578 399 304 265 333 378 352 335
– 5.4 – – – 3.0 – – – – – –
– -5.4 – – – – – – – – – –
26 30 24 25 25 31 28 28 33 40 37 42
23 28 22 23 24 31 27 28 33 38 35 41
3.5 1.4 1.3 1.2 1.3 1.3 1.3 1.4 1.2 0.8 0.7 0.7
1.0 2.5 3.7 1.6 2.1 1.7 3.4 2.5 1.7 0.8 2.5 3.7
469 454 426 656 628 590 552 492 451 409 366 322
-177 -201 -238 -280 -321 -368 -417 -487 -537 -588 -638 -691
43 43 43 55 58 59 59 59 59 59 59 61

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?